Microbial-based Tools to Combat COVID-19

ECI Conference on Microbial Engineering Webinar

Webinar Presentations Available Here

January 26, 2021
10:00 – 12:30 (New York) – 15:00 – 17:30 (London)

Barry Buckland, BiologicB, USA
Eli Keshavarz-Moore, UCL, UK

Our community has made extraordinary progress toward developing a number of promising vaccine candidates to provide protection against COVID-19 disease.  Because of the pandemic, we have postponed the face-to-face Microbial Engineering II conference to September 19-23, 2021 in Albufeira, Portugal. To keep the community up to date, this webinar will focus on a variety of programs based either on microbial platforms or cell free synthesis. Each speaker will entertain participant questions. 

Confirmed Speakers

John Liddell, CPI, UK 
“Microbial technology supporting
COVID-19 vaccine development”

Kathrin Jansen, Pfizer, USA
“Learnings from the development of a
COVID-19 RNA vaccine”

Vikram Paradkar, Biological E, India
“Development of COVID-19 vaccine based on receptor binding domain from
spike protein of SARS-CoV-2”

Ronen Tchelet, Dyadic International, USA
“C1- A a low cost production platform to combat COVID-19 pandemic”.

Andrey Zarur, Greenlight Biosciences, USA
“Scaling cell free synthesis of mRNA to enable global herd immunity through COVID-19 vaccine.

Robert Juba Jr.,  Inovio, USA
“Leveraging a plasmid DNA platform
for COVID-19 vaccine development”

Mark Bodmer, EVELO, USA
“From worms to the small intestinal axis – a new approach to resolving systemic inflammation caused by COVID-19”. 

  • Participant Login

    To sign in as a participant, please visit our registration portal.
  • Add Email

    To ensure receipt of ECI mailings, please add 'eci@informz.net' to your address book.
  • Page Sections